Moderna
MRNA
#291
Rank
S$101.97 B
Marketcap
S$252.04
Share price
-1.91%
Change (1 day)
698.13%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of June 2026 : S$8.71 Billion

According to Moderna 's latest financial reports the company has S$8.71 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$S$11.10 B-25.05%
2024-12-31$S$14.81 B-19.02%
2023-12-31$S$18.29 B-28.63%
2022-12-31$S$25.63 B34.06%
2021-12-31$S$19.12 B464.42%
2020-12-31$S$3.38 B113.91%
2019-12-31$S$1.58 B-24.24%
2018-12-31$S$2.09 B149.96%
2017-12-31$S$0.83 B-31.36%
2016-12-31$S$1.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$105.09 B 1,105.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$48.42 B 455.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$54.12 B 520.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$88.98 M-98.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$46.92 Million-100.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$4.64 B-46.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$0.60 B-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA